This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Dennis Stone - Innovator in Biological Activity Measurement
Introduction
Dennis Stone is an accomplished inventor based in Telford, PA (US). He has made significant contributions to the field of biological research, particularly in the measurement of receptor activity. His innovative approach has the potential to advance our understanding of biological processes.
Latest Patents
Dennis Stone holds a patent for a method of measuring the biological activity of an urotensin II receptor. The patent describes how the administration of U-II to rats resulted in an increase in the redness or skin temperature of the rats' ears. This increase was inhibited by compounds that decrease the biological activity of the U-II/UT receptor. The invention provides methods for measuring the biological activity of an U-II receptor by monitoring the redness or skin temperature of an animal's ear. It also outlines the use of these methods to test compounds for their abilities to influence the biological activity of the U-II receptor.
Career Highlights
Dennis Stone is currently employed at Janssen Pharmaceutica NV, where he continues to engage in innovative research. His work focuses on the intersection of pharmacology and biological measurement, contributing to advancements in medical science.
Collaborations
Dennis has collaborated with notable colleagues, including Robert Schulingkamp and Raymond W. Colburn. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Dennis Stone's contributions to the field of biological activity measurement exemplify the impact of innovative thinking in scientific research. His work not only advances our understanding of receptor activity but also opens new avenues for testing potential therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
